Table 2.
Multidrug-resistant organism carriage according to site
| Urinary | Rectal | Respiratory | Cutaneous / Wound | |
|---|---|---|---|---|
| ESBL Enterobacteriaceae | 30 | 59 | 2 | 13 |
| CRE (NDM + OXA types) | 1 | 2 | 0 | 0 |
| CASE Enterobacteriaceae | 0 | 1 | 0 | 0 |
| ESBL Pseudomonas aeruginosa | 1 | 0 | 0 | 3 |
| Carba-R P. aeruginosa | 0 | 2 | 0 | 2 |
| Cefta-R P. aeruginosa | 0 | 2 | 3 | 0 |
| ESBL Acinetobacter baumanii | 0 | 1 | 0 | 0 |
| OXA-23 A. baumanii | 0 | 2 | 0 | 0 |
| Cefta-R A. baumanii | 0 | 1 | 0 | 0 |
| MRSA | 3 | 0 | 19 | 4 |
| VRE | 0 | 1 | 0 | 0 |
ESBL Extended-spectrum beta-lactamase; CRE Carbapenem-resistant Enterobacteriaceae; CASE Cephalosporinase; Carba-R Carbapenem-resistant; Cefta-R Ceftaroline-resistant; MRSA Methicillin-resistant Staphylococcus aureus; VRE Vancomycin-resistant Enterococci